Laura Lovett

By Laura Lovett 01:13 pmApril 25, 2018
Like almost any field in the healthcare industry pharma wants to get in on the latest technology trends. Recently big pharma has been looking to artificial intelligence as another tool to help facilitate drug research and help the company progress.  At the World Medical Innovation Forum in Boston on April 24, a panel of pharma leaders discussed the future of AI in the industry.  “It's quite top...
By Laura Lovett 04:56 pmApril 23, 2018
San Francisco-based startup Luma Health this morning released its two-way communication chatbot, called Care Pathway Messaging. The new services offers a messaging system for patients and providers.  “I would define it was as the Swiss Army knife of clinical messaging,” Dr. Tashfeen Ekram, cofounder and chief medical officer, told MobiHealthNews. “[The system] allows us to be able to send highly...
By Laura Lovett 02:16 pmApril 23, 2018
A quick Google image search is often the go-to for people when they notice a rash cropping up on their skin. This starts the process of trying to match up their skin condition to the one in the photos.  But a new app called Skin Image Search by First Derm has just launched in beta today and aims to use artificial intelligence to help people figure out exactly what their skin condition is.  “In...
By Laura Lovett 03:17 pmApril 20, 2018
Forty mph winds pelted cold rain against the runners as they approached the Boston Marathon’s infamous Heartbreak Hill. It was just before this mark that runner Courtney Duckworth’s eyesight started to blur. She couldn’t tell if her senses were warped from the terrible weather conditions or if it was something more serious. Living with Type 1 diabetes, she is used to keeping track of her health...
By Laura Lovett 02:24 pmApril 19, 2018
Vicarious Surgical, a startup that combines virtual reality with surgical robotics, just landed $16.75 million in a Series A funding round led by Vinod Khosla's Khosla Ventures and Eric Schmidt’s Innovation Endeavors, with participation from Bill Gates’ Gates Ventures, Jerry Yang’s AME Cloud Ventures and Marc Benioff. The company plans to use the money to support the next growth phase and build...
By Laura Lovett 11:24 amApril 19, 2018
Data analytics startup Trayt is launching a new app that helps patients living with neurodevelopmental and brain disorders, as well as their caregivers, track behavioral and non-behavioral symptoms. The app has a comorbid rating scale, as well as measurements of how effective treatments are. It can also give progress reports and provides users with actionable insights.  “As a parent of a child...
By Laura Lovett 03:53 pmApril 18, 2018
As the opioid epidemic continues to make its mark on the nation, healthcare professionals, innovators, and government officials are trying to come up with solutions. An article recently published in NEJM Catalyst suggests that using a texting system could help reduce opioid relapses, as well as keep costs down.  The article — which was coauthored by Epharmix's chief medical officer, a Preferred...
By Laura Lovett 01:27 pmApril 18, 2018
Digital health appears to be making its way onto the national stage. Yesterday, FDA Commissioner Scott Gottlieb gave the field a shout-out in his remarks to the US House Subcommittee on Agriculture, Rural Development concerning the Fiscal Year 2019 budget request for the FDA.  “The Budget requests new resources for the FDA to make significant investments in advancing critical areas of science,...
By Laura Lovett 09:48 amApril 18, 2018
Depression among college students has become a hot topic on university campuses as the number of students seeking treatment for this condition continues to grow.  Now Finnish Student Health System, Meru Health and eClinicalHealth are teaming up to study the efficacy and feasibility of a digital therapeutic intervention for depression in a randomized-controlled clinical trial.  “The number of...
By Laura Lovett 03:18 pmApril 17, 2018
A new clinical validation study, published in the Journal of Clinical Oncology CCI, found that Medial EarlySign’s artificial intelligence tool flagged about 8 percent of patients in a large trial group that were later diagnosed with cancer or precancerous lesions.  “The implementation of machine-learning based algorithms to risk stratify populations at risk is commonly feared by many clinicians...